Can semaglutide reduce alcohol consumption? New research explores its role in alcohol use disorder and obesity.

A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential for novel treatments pending further clinical ...

Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...

Semaglutide (the active ingredient in Ozempic and Wegovy) and other GLP-1 medications have rapidly become some of the most popular drugs in the world. Originally developed for type 2 diabetes, GLP-1s ...

Researchers at the University of Colorado Anschutz Medical Campus observed unusual changes in brain connectivity while ...

Findings show risk cut in half based on electronic health record data. (HealthDay News) — Semaglutide may cut incidence and recurrence of alcohol use disorder (AUD) in patients with obesity, according ...

A new study has revealed another benefit of the diabetes medication turned weight loss drug Ozempic. Health experts now say it could also help those with alcohol-use disorder. A study published this ...

Please provide your email address to receive an email when new articles are posted on . Participants on semaglutide had reduced risk for hospitalization due to preexisting alcohol use disorder, ...

A man prescribed semaglutide for obesity saw his drinking fall dramatically over 10 months, adding fresh real-world evidence to the idea that GLP-1 drugs may help curb alcohol cravings while ...

A Danish trial found that semaglutide, a drug used for weight loss and diabetes, significantly reduced heavy drinking and ...